Tactile Systems Technology (TCMD) reported $330M in revenue for fiscal 2025, +12.5% year on year. That ranks #2440 by revenue among 2853 SEC filers and #241 in Healthcare. Net income was $19.1M, a net margin of 5.8%. Revenue has grown 16.3% a year on average since 2016 ($84.5M then). The fiscal 2025 balance sheet shows $274M in total assets, $83.4M in cash and $0 in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $330M | +12.5% | FY20252025-12-31 |
| Gross profitGrossProfit | $250M | +15.4% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $29.3M | +32.0% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $19.1M | +12.5% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $42.8M | +5.3% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $2.4M | −0.5% | FY20252025-12-31 |
| Total assetsAssets | $274M | −8.0% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $219M | +1.1% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $83.4M | −11.6% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $0 | −100.0% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $75.3M | −$1.8M | Open → |
| Q2 20262026-06-30 | $85.7M | $7.8M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Tactile Systems Technology Inc
- Ticker
- TCMD
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0001027838
Filings
- 10-QAug 10, 2026Open filing →
- 10-QMay 4, 2026Open filing →
- 10-KFeb 17, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| MannkindMNKD | $349M | $5.9M |
| InogenINGN | $349M | $22.7M |
| Castle BiosciencesCSTL | $344M | −$24.2M |
| Tactile Systems TechnologyTCMD | $330M | $19.1M |
| Fulgent GeneticsFLGT | $323M | −$60.5M |
| DocgoDCGO | $322M | −$196M |
| AngiodynamicsANGO | $320M | −$36.7M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Tactile Systems Technology — Key figures |url=https://companiesranked.com/en/company/tactile-systems-technology |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Tactile Systems Technology — Key figures. CompaniesRanked. https://companiesranked.com/en/company/tactile-systems-technologyBibTeX
@misc{companiesranked-en-company-tactile-systems-technology-2026,
author = {{CompaniesRanked}},
title = {{Tactile Systems Technology — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tactile-systems-technology}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-016380 · February 17, 2026
{{cite web |title=Tactile Systems Technology — Key figures — 10-K (0001104659-26-016380) |url=https://www.sec.gov/Archives/edgar/data/1027838/000110465926016380/tcmd-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.